Chief Medical Officer

Executive Assistant To Chief Executive Officer

The biggest biotech funding rounds in September 2025

Transcript : Mineralys Therapeutics, Inc. Presents at H.C. Wainwright 27th Annual Global Investment Conference, Sep-09-2025 09

Mineralys Therapeutics Completes Enrollment in Phase 2 EXPLORE-OSA Trial of Lorundrostat in Obstructive Sleep Apnea and Hypertension

6 Stocks Goldman Sachs Says Are Poised For Potential Acquisition In Next 12 Months — Including A Huge 200% Winner

Senior Director, Scientific Communications

Mineralys Therapeutics is a publicly traded, clinical-stage biotechnology company focused on developing medicines for diseases driven by abnormally elevated aldosterone. The Sr. Director, Scientific Communications will lead the strategy and execution of scientific communications, medical information, and publication planning in support of the company’s pipeline and eventual commercial launch.

Sign up with Google

Sign in with Google